A summary of important health news from the past week.
South Florida hospitals closing ahead of Hurricane Irma
Hospitals in southern Florida, including some in Monroe County and Miami, are evacuating in preparation for incoming Hurricane Irma. Mercy Hospital in Miami, for instance, has begun to evacuate more than 200 patients and has closed its emergency room. Hospitals also see an increase in hurricane preparation-related injuries, such as those obtained while putting up shutters.
The FDA's center for digital health is growing rapidly; the team is seeking to hire entrepreneurs-in-residence to keep up with the trends of health information technology. The effort to recruit a team of 13 who is both tech and business-savvy sheds light on the evolving field of digital health, which has attracted more than $10B in funding in the past few years. This announcement follows the FDA's passing of a pilot program that expedites the approval-process for emerging software companies in digital health.
By: Daniel Green
It seems that everyone is worried about their weight and the health risks associated with being overweight. This is especially true now, seeing that so many Americans are overweight or obese. When setting fitness goals many are not consistent and often fall back into old habits. This article points out five steps that are helpful in starting your fitness journey off right so that you stay focused on achieving your goals for your physical health.
US heroin deaths jump 533% since 2002, report says
The US government's newest report on drug abuse in America has found, since 2002, a 135% increase in heroin use, and a 533% increase in heroin deaths. These startling statistics highlight the rapidly growing opioid misuse, which includes both prescription medications and illegal drugs. Dr. Andrew Kolodny, Physicians for Responsible Opiod Prescribing's executive director, argues that the lack of access to drug addiction treatments - such as programs and medications - is part of the opioid misuse epidemic and believes that providing more treatments could be effective in reducing these astonishing numbers.
The FSA has accused Pfizer of not fully investigating cases wherein patients died or became severely ill when the EpiPen failed to work properly. Pfizer reportedly received hundreds of complaints of this nature. Pfizer officials, however, note that they ship millions of EpiPens to consumers and that they have no information on a causal connection between an EpiPen and deaths.
Who We Are
The Center is the hub of the science of human health for students, faculty, and staff at Emory University.